QA: Cellectar Biosciences Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001279704_2023_Cellectar_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001279704, Cellectar Biosciences Inc.

  xvar xval
0 AssetsCurrent 20,529,601
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 418,641
3 remainder_Assets 641,548
4 LiabilitiesCurrent 5,529,290
5 LiabilitiesNoncurrent 552,981
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 9,594,170
9 ResearchAndDevelopmentExpense 19,219,603
10 remainder_Expenses -60,000
11 remainder_Revenues 0
12 remainder_NetIncome 152,519
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 21,589,790
1 Liabilities 6,082,271
2 Expenses 28,753,773
3 Revenues 0
4 StockholdersEquity 15,507,519
5 NetIncome -28,601,254
6 ComprehensiveNetIncome -28,601,254
7 BaseVar 28,289,176
8 EconomicCapitalRatio -0.139

Edgar->Model Mapping

Feature Distribution

Change over Time